Simcere Pharmaceutical Group Company Profile (NYSE:SCR)

About Simcere Pharmaceutical Group (NYSE:SCR)

Simcere Pharmaceutical Group logoSimcere Pharmaceutical Group (Simcere) is a holding company. The Company principally engaged in the research, development, manufacture and distribution of pharmaceutical and vaccine products in the People's Republic of China. Company markets and sells its products directly or indirectly to approximately 1,405 pharmaceutical distributors who in turn sell these products to other distributors, hospitals and retail pharmacies throughout China. As of March 31, 2013, the Company also had over 11 product candidates in various stages of development, including treatments for cancer and cardiovascular diseases. In December 2013, Simcere completed the merger contemplated by the previously announced Agreement and Plan of Merger among the Company, Simcere Holding Limited (Parent) and Simcere Acquisition Limited (Merger Sub), and as a result of the merger, the Company became a wholly owned subsidiary of Parent.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Pharmaceuticals - NEC
  • Sub-Industry: N/A
  • Symbol: NYSE:SCR
  • CUSIP: N/A
  • Web: www.simcere.com
Average Prices:
  • 50 Day Moving Avg: $8.00
  • 200 Day Moving Avg: $8.00
P/E:
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0
Dividend:
  • Dividend Yield: 1.0%
Profitability:
  • Net Margins: 0.62%
  • Return on Equity: 1.60%
  • Return on Assets: 0.33%
 
Frequently Asked Questions for Simcere Pharmaceutical Group (NYSE:SCR)

What is Simcere Pharmaceutical Group's stock symbol?

Simcere Pharmaceutical Group trades on the New York Stock Exchange (NYSE) under the ticker symbol "SCR."

Who are some of Simcere Pharmaceutical Group's key competitors?

How do I buy Simcere Pharmaceutical Group stock?

Shares of Simcere Pharmaceutical Group can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.


MarketBeat Community Rating for Simcere Pharmaceutical Group (NYSE SCR)
Community Ranking:  1.6 out of 5 ()
Outperform Votes:  13 (Vote Outperform)
Underperform Votes:  28 (Vote Underperform)
Total Votes:  41
MarketBeat's community ratings are surveys of what our community members think about Simcere Pharmaceutical Group and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Simcere Pharmaceutical Group (NYSE:SCR) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Simcere Pharmaceutical Group (NYSE:SCR)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
9/28/2015Royal Bank Of CanadaReiterated RatingSector Perform€34.00N/AView Rating Details
(Data available from 7/24/2015 forward)

Earnings

Earnings History for Simcere Pharmaceutical Group (NYSE:SCR)
Earnings by Quarter for Simcere Pharmaceutical Group (NYSE:SCR)
Earnings History by Quarter for Simcere Pharmaceutical Group (NYSE SCR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/14/2013Q3$0.06$0.51$78.50 million$68.80 millionViewListenView Earnings Details
8/13/2013Q2 2013$0.12$0.03$91.58 million$78.70 millionViewListenView Earnings Details
5/9/2013Q1 2013$0.08$0.09$85.10 millionViewListenView Earnings Details
3/7/2013Q4 2012($0.06)$88.06 million$86.70 millionViewListenView Earnings Details
11/15/2012Q312$0.07$0.07$85.72 million$83.80 millionViewN/AView Earnings Details
8/10/2012$0.11$0.08ViewN/AView Earnings Details
5/9/2012$0.08$0.08ViewN/AView Earnings Details
3/7/2012$0.05$0.12ViewN/AView Earnings Details
11/14/2011$0.14$0.10ViewN/AView Earnings Details
8/9/2011$0.13$0.21ViewN/AView Earnings Details
5/10/2011$0.11$0.08ViewN/AView Earnings Details
3/8/2011$0.10$0.17ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Simcere Pharmaceutical Group (NYSE:SCR)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Simcere Pharmaceutical Group (NYSE:SCR)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Simcere Pharmaceutical Group (NYSE:SCR)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for Simcere Pharmaceutical Group (NYSE:SCR)
Latest Headlines for Simcere Pharmaceutical Group (NYSE:SCR)
Source:
No headlines for this company have been tracked by MarketBeat.com

Social

Chart

Simcere Pharmaceutical Group (SCR) Chart for Monday, July, 24, 2017

This page was last updated on 7/24/2017 by MarketBeat.com Staff